Community Health Systems Inc (CYH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $315.90M
Last updated: Nov 17, 2026 at 11:03 AM ET
Community Health Systems Inc (CYH) Earnings: Report Dates and Results
Community Health Systems (CYH) is expected to report earnings on Feb 16, 2027. In the quarter ended Sep 30, 2026, Community Health Systems reported EPS of -$0.48, below the -$0.22 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CYH has an expected report date of Feb 16, 2027.
CYH Earnings Call
The latest CYH earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 37 quarters below that had an estimate, CYH beat 21, missed 15 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $2.76B, down 10.7% from $3.09B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.48 | -$0.22 | N/A | -118.18% | Miss | -137.8% | 5 | 0 up, 4 down | Oct 28, 2026 | $2.76B |
| Jun 30, 2026 | -$0.19 | -$0.18 | -$0.32 - $0.00 | -5.56% | Miss | N/A | 7 | 4 up, 1 down | Jul 22, 2026 | $2.83B |
| Mar 31, 2026 | -$0.48 | -$0.05 | -$0.26 - $0.11 | -860.00% | Miss | N/A | 6 | 0 up, 0 down | Apr 21, 2026 | $2.96B |
| Dec 31, 2025 | $0.80 | -$0.32 | -$0.35 - $0.41 | +350.91% | Beat | N/A | 6 | 0 up, 5 down | Feb 18, 2026 | $3.11B |
| Sep 30, 2025 | $1.27 | -$0.28 | -$0.48 - -$0.18 | +553.57% | Beat | N/A | 6 | 0 up, 1 down | Oct 23, 2025 | $3.09B |
| Jun 30, 2025 | -$0.05 | -$0.10 | -$0.32 - -$0.03 | +50.00% | Beat | N/A | 8 | 0 up, 1 down | Jul 23, 2025 | $3.13B |
| Mar 31, 2025 | -$0.03 | -$0.10 | -$0.17 - -$0.05 | +70.00% | Beat | N/A | 8 | 0 up, 1 down | Apr 23, 2025 | $3.16B |
| Dec 31, 2024 | -$0.42 | -$0.06 | -$0.69 - $0.07 | -663.64% | Miss | N/A | 7 | 0 up, 1 down | Feb 18, 2025 | $3.26B |
| Sep 30, 2024 | -$0.30 | -$0.18 | -$0.29 - -$0.02 | -66.67% | Miss | N/A | 8 | 0 up, 0 down | Oct 23, 2024 | $3.09B |
| Jun 30, 2024 | -$0.17 | -$0.12 | -$0.15 - -$0.07 | -41.67% | Miss | N/A | 8 | 0 up, 0 down | Jul 24, 2024 | $3.14B |
| Mar 31, 2024 | -$0.14 | -$0.14 | -$0.21 - -$0.07 | 0.00% | In line | N/A | 8 | 0 up, 0 down | Apr 24, 2024 | $3.14B |
| Dec 31, 2023 | -$0.41 | $0.06 | $0.01 - $0.12 | -783.33% | Miss | -127.3% | 7 | 0 up, 0 down | Feb 20, 2024 | $3.18B |
| Sep 30, 2023 | -$0.33 | -$0.16 | -$0.23 - -$0.10 | -106.25% | Miss | N/A | 7 | 0 up, 2 down | Oct 25, 2023 | $3.09B |
| Jun 30, 2023 | -$0.22 | -$0.26 | -$0.37 - -$0.13 | +15.38% | Beat | N/A | 9 | 1 up, 0 down | Aug 2, 2023 | $3.12B |
| Mar 31, 2023 | -$0.43 | -$0.16 | -$0.43 - -$0.01 | -168.75% | Miss | -407.1% | 9 | 0 up, 1 down | May 1, 2023 | $3.11B |
| Dec 31, 2022 | $1.50 | $0.37 | -$0.23 - $1.19 | +305.41% | Beat | +30.4% | 9 | 0 up, 0 down | Feb 15, 2023 | $3.14B |
| Sep 30, 2022 | -$0.52 | -$0.02 | -$0.61 - $0.43 | N/A | N/A | -175.4% | 10 | 0 up, 0 down | Oct 26, 2022 | $3.02B |
| Jun 30, 2022 | -$2.52 | $0.05 | -$0.27 - $0.24 | N/A | N/A | -1195.7% | 10 | 0 up, 1 down | Jul 27, 2022 | $2.93B |
| Mar 31, 2022 | $0.14 | $0.10 | -$0.06 - $0.40 | +40.00% | Beat | -61.1% | 7 | 0 up, 0 down | Apr 27, 2022 | $3.11B |
| Dec 31, 2021 | $1.15 | $0.61 | $0.14 - $0.62 | +88.52% | Beat | +19.8% | 11 | 0 up, 0 down | Feb 16, 2022 | $3.23B |
| Sep 30, 2021 | $0.69 | $0.12 | -$0.06 - $0.40 | +475.00% | Beat | +283.3% | 10 | 0 up, 0 down | Oct 27, 2021 | $3.12B |
| Jun 30, 2021 | $0.23 | $0.01 | -$0.13 - $0.10 | N/A | N/A | -72.9% | 10 | N/A | Jul 28, 2021 | $3.01B |
| Mar 31, 2021 | $0.36 | -$0.16 | -$0.37 - $0.12 | +325.00% | Beat | N/A | 10 | N/A | Apr 28, 2021 | $3.01B |
| Dec 31, 2020 | $0.96 | $0.20 | -$0.52 - $1.26 | +380.00% | Beat | +140.0% | 11 | N/A | Feb 17, 2021 | $3.72B |
| Sep 30, 2020 | $0.18 | -$0.11 | -$1.00 - $1.32 | +263.64% | Beat | N/A | 11 | N/A | Oct 27, 2020 | $3.13B |
| Jun 30, 2020 | $0.85 | -$0.83 | -$2.01 - $0.26 | +202.41% | Beat | N/A | 9 | N/A | Jul 28, 2020 | $2.52B |
| Mar 31, 2020 | -$1.59 | -$0.58 | -$1.18 - -$0.22 | -174.14% | Miss | N/A | 13 | N/A | Apr 28, 2020 | $3.02B |
| Dec 31, 2019 | $0.40 | -$0.46 | -$0.77 - -$0.11 | +186.96% | Beat | N/A | 13 | N/A | Feb 19, 2020 | $3.29B |
| Sep 30, 2019 | -$0.29 | -$0.59 | -$0.80 - -$0.23 | +50.85% | Beat | N/A | 13 | N/A | Oct 29, 2019 | $3.25B |
| Jun 30, 2019 | -$0.47 | -$0.51 | -$0.94 - -$0.36 | +7.84% | Beat | N/A | 15 | N/A | Aug 5, 2019 | $3.30B |
| Mar 31, 2019 | -$0.53 | -$0.45 | -$0.86 - -$0.20 | -17.78% | Miss | -507.7% | 16 | N/A | Apr 30, 2019 | $3.38B |
| Dec 31, 2018 | -$0.42 | -$0.60 | -$0.71 - -$0.34 | +30.00% | Beat | N/A | 17 | N/A | Feb 20, 2019 | $3.45B |
| Sep 30, 2018 | -$1.64 | -$1.02 | -$1.30 - -$0.57 | -60.78% | Miss | N/A | 17 | N/A | Oct 29, 2018 | $3.45B |
| Jun 30, 2018 | -$0.01 | -$0.43 | -$0.61 - -$0.25 | +97.67% | Beat | N/A | 16 | N/A | Jul 26, 2018 | $3.56B |
| Mar 31, 2018 | $0.13 | -$0.19 | -$0.47 - $0.32 | +168.42% | Beat | +62.5% | 17 | N/A | May 1, 2018 | $3.69B |
| Dec 31, 2017 | -$0.25 | -$0.34 | -$0.63 - -$0.14 | +26.47% | Beat | -154.3% | 18 | N/A | Feb 27, 2018 | $3.06B |
| Sep 30, 2017 | -$0.77 | -$0.30 | -$0.79 - -$0.11 | -156.67% | Miss | N/A | 16 | N/A | Nov 1, 2017 | $3.67B |
| Jun 30, 2017 | -$0.25 | -$0.12 | -$0.29 - $0.19 | -108.33% | Miss | -377.8% | 20 | N/A | Aug 1, 2017 | $4.14B |
| Mar 31, 2017 | $0.08 | $0.13 | N/A | -38.46% | Miss | -70.4% | N/A | N/A | May 1, 2017 | $4.49B |
| Dec 31, 2016 | $0.46 | $0.13 | N/A | +253.85% | Beat | N/A | N/A | N/A | Feb 20, 2017 | $2.31B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $1.99, a profit after a loss of $1.03 per share the year before. It was $0.47 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $1.99 | N/A |
| Dec 31, 2024 | -$1.03 | N/A |
| Dec 31, 2023 | -$1.39 | N/A |
| Dec 31, 2022 | -$1.40 | -157.6% |
| Dec 31, 2021 | $2.43 | +507.5% |
| Dec 31, 2020 | $0.40 | N/A |
| Dec 31, 2019 | -$0.89 | N/A |
| Dec 31, 2018 | -$1.94 | N/A |
| Dec 31, 2017 | -$1.19 | -353.2% |
| Dec 31, 2016 | $0.47 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,900 words across 11 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 5,861 | 11 | |
| 2026Q2 | Jun 30, 2026 | 5,337 | 11 | |
| 2026Q1 | Mar 31, 2026 | 4,035 | 9 | |
| 2025Q4 | Dec 31, 2025 | 5,691 | 11 | |
| 2025Q3 | Sep 30, 2025 | 4,517 | 11 | |
| 2025Q2 | Jun 30, 2025 | 6,535 | 11 | |
| 2025Q1 | Mar 31, 2025 | 5,220 | 9 | |
| 2024Q4 | Dec 31, 2024 | 5,617 | 9 |
2026Q3 Earnings Call
Opening remarks
Anton Hie Vice President of Investor Relations Thank you, Rocco. Good morning, and welcome to Community Health Systems third quarter 2026 conference call. Joining me on today's call are Kevin Hammons, Chief Executive Officer, and Jason Johnson, Executive Vice President and Chief Financial Officer. Before we begin, I must remind everyone that this conference call may contain certain forward-looking statements, including all statements that do not relate solely to historical or current facts. These forward-looking statements are subject to a number of known and unknown risks, which are described in headings such as Risk Factors in our annual report on Form 10-K and other reports filed with or furnished to the SEC. Actual results may differ significantly from those expressed in any forward-looking statements in today's discussion. We do not intend to update any of these forward-looking statements. Yesterday afternoon, we issued a press release with our financial statements and definitions and calculations of adjusted EBITDA and adjusted EPS. We have also posted a supplemental slides presentation on our website. All calculations we discuss today will exclude gains or losses from early extinguishment of debt, impairment gains or losses on the sale of businesses, expense from government and other legal matters and related costs, expense from employee termination benefits and other restructuring charges, and business transformation costs. With that said, I will turn the call over to Kevin Hammons, Chief Executive Officer.
Kevin Hammons Chief Executive Officer Thank you, Anton. Good morning, everyone, and thank you for joining our third quarter 2026 conference call and for your continued interest in CHS. I want to begin by expressing my sincere appreciation to our dedicated clinical and operational teams across all of our facilities. Their steadfast commitment enables us to advance our core vision, making the healthcare experience exceptional for our patients, our communities, and each other. Even with the dynamic operating landscape, shaped by shifting coverage dynamics and broader macroeconomic pressures, we are taking direct, proactive steps to fortify our competitive position. Our execution remains anchored in our core operational priorities: elevating clinical quality, enhancing the patient and physician experience, and strengthening our employee engagement. Building on the quality momentum we shared last quarter, including strong Leapfrog safety grades across our network, our facilities continue to deliver outstanding clinical outcomes. In the third quarter, we further reduced our severe sepsis and septic shock mortality rates and hospital-acquired infection metrics, continuing to outperform national benchmarks. This commitment to clinical excellence is not just an operational milestone. It directly positions CHS as the provider of choice in our communities, creating a distinct competitive advantage that positions us to expand market share as patient demand normalizes and to achieve sustainable growth into the future.
Frequently Asked Questions About CYH
When is Community Health Systems's next earnings date?
Community Health Systems's next earnings report is expected for Feb 16, 2027.
Did CYH beat earnings estimates last quarter?
No. Community Health Systems reported EPS of -$0.48 for the quarter ended Sep 30, 2026, below the -$0.22 estimate by 118.18%.
What EPS do analysts expect from CYH next quarter?
The consensus EPS estimate for Community Health Systems for the quarter ending Dec 31, 2026 is -$0.02 from 10 analysts, with estimates from -$0.35 to $0.42.
How often does CYH beat earnings estimates?
Community Health Systems beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -77.86%.
CYH pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts